Product
Supplier
Encyclopedia
Inquiry
Uridine 5-diphosphate disodium salt (UDP-Na2), CAS 27821-45-0 buy - large image1
Uridine 5-diphosphate disodium salt (UDP-Na2), CAS 27821-45-0 buy - image1

Uridine 5-diphosphate disodium salt (UDP-Na2), CAS 27821-45-0

Unit Price: Get Latest Price
CAS No.:

27821-45-0

Content:

95%

Port:

shanghai

Packaging:

25kg/barrel

Price valid (until):

2025-12-24

Company Type:
Manufactory
Location:
China
Qualification:
Main Products:

nucleotide,enzyme preparatio,nucleotide monophosphate,nucleotide diphosphate

  • Product Description

  • Seller Information

  • Description



    Name:Uridine 5’-diphosphate disodium salt
    Aliases:UDP-Na2;5’-UDP,2Na
    CAS No.27821-45-0
    Molecular formula:C9H12O12N2P2Na2
    Molecular weight:448.12
    Physical properties:
    This product is a white powder; freely soluble in water, insoluble in ethanol.
    Purity HPLC:≥95.0%
    Contents dry basis:≥85.0%
    Storage:Preserve in tight,light-resistant containers, in a freezing place.

    Items Specifications






    Basic Info
    Product Name:

    Uridine 5′-(trihydrogen diphosphate), sodium salt (1:2)

    CAS No.:

    27821-45-0

    Molecular Formula:

    C9H14N2O12P2.2Na

    InChIKeys:

    InChIKey=XQXKBIQDEUFQJC-WFIJOQBCSA-N

    Hazard Identification

    Classification of the substance or mixture

    Skin irritation, Category 2

    Eye irritation, Category 2

    Specific target organ toxicity – single exposure, Category 3

    GHS label elements, including precautionary statements

    Pictogram(s)
    Signal word

    Warning

    Hazard statement(s)

    H315 Causes skin irritation

    H319 Causes serious eye irritation

    H335 May cause respiratory irritation

    Precautionary statement(s)
    Prevention

    P264 Wash ... thoroughly after handling.

    P280 Wear protective gloves/protective clothing/eye protection/face protection/hearing protection/...

    P261 Avoid breathing dust/fume/gas/mist/vapours/spray.

    P271 Use only outdoors or in a well-ventilated area.

    Response

    P302+P352 IF ON SKIN: Wash with plenty of water/...

    P321 Specific treatment (see ... on this label).

    P332+P317 If skin irritation occurs: Get medical help.

    P362+P364 Take off contaminated clothing and wash it before reuse.

    P305+P351+P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.

    P304+P340 IF INHALED: Remove person to fresh air and keep comfortable for breathing.

    P319 Get medical help if you feel unwell.

    Storage

    P403+P233 Store in a well-ventilated place. Keep container tightly closed.

    P405 Store locked up.

    Disposal

    P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.

    Other hazards which do not result in classification

    no data available

    Handling and Storage

    Precautions for safe handling

    Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.

    Conditions for safe storage, including any incompatibilities

    Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.

  • Seller Information
    Business Type:

    Manufactory

    Main Products:

    nucleotide,enzyme preparatio,nucleotide monophosphate,nucleotide diphosphate

    Location:

    Heda Pharmaceutical Valley,NO 501.Fucheng Road, Xiasha Economic&Technological Development Zone, Qiantang District, Hangzhou City, Zhejiang Province,China

    Payment Terms:

    TT against copy of documents

    Average lead Time:

    3

    Total Annual Revenue:

    $50 million-$100 million

    Total Employees:

    101-200

    Year of Establishment:

    2006

    Certifications:

    Quality system certification,ORTHODOX UNION,HALAL-CERTIFICATE

    Company Hangzhou Meiya Pharmaceutical Co., Ltd. which was founded in March of 2006, is mainly engaged in nucleotide series products, and it is a listed enterprise on the National Equities Exchange and Quotations(Stock Code: 833650). The predecessor of the company was Hangzhou Meiya Biotechnology Co., Ltd, which was founded in 1998. Through the whole progress, the company is always focusing on the development and production of preparation process, as well as process improvement. In November of 2012, Hangzhou Meiya set a wholly-owned company as its sales center: Shanghai Nucleosides Bio-Technology Co., Ltd. In January of 2014, Hangzhou Meiya set another wholly-owned company as its production site: Meiya Haian Pharmaceutical Co., Ltd., with a total investment exceeding 120 million RMB. Meiya has the Drug Production License and nearly 10,000 square meters of workshop of which meets GMP requirements.
      Hangzhou Meiya, Shanghai Nucleosides Bio-Technology, and Meiya Haian Pharmaceutical all have their own import and export rights. Meiya produces more than 50 varieties, including nucleoside, nucleotide monophosphate, nucleotide diphosphate, nucleotide triphosphate, cyclic nucleotide, polynucleotide, yeast nucleotide, enzyme preparation, etc. Meiya is one of the top nucleotide manufacturers in China.Profile
  • Country Product Purchase Quantity Date Posted
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.